Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Rhythm Pharmaceuticals Inc
(NQ:
RYTM
)
49.68
+3.56 (+7.72%)
Streaming Delayed Price
Updated: 2:32 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Rhythm Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
Next >
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session
August 02, 2022
Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
Via
Benzinga
Why U.S. Stocks Are Trading Lower; Job Openings Drop To This Level In June
August 02, 2022
U.S. stocks traded lower this morning, with the Dow Jones falling more than 250 points on Tuesday.
Via
Benzinga
Why Shares Of Rhythm Pharmaceuticals Are Soaring
July 20, 2022
Rhythm Pharmaceuticals, Inc.
Via
Benzinga
Rhythm Pharma's Setmelanotide Shows Encouraging Action In Hypothalamic Obesity Study
July 12, 2022
Via
Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Rhythm Pharmaceuticals: Q2 Earnings Insights
August 02, 2022
Rhythm Pharmaceuticals (NASDAQ:RYTM) reported its Q2 earnings results on Tuesday, August 2, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Rhythm Pharmaceuticals's Earnings: A Preview
August 01, 2022
Rhythm Pharmaceuticals (NASDAQ:RYTM) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Recap Of Friday's Biotech Catalysts - End Of The Day Summary
July 22, 2022
Via
Benzinga
Rhythm Has Tripled In A Week And Quintupled Since May — Here's Why
July 21, 2022
The company looks to take on behemoths Novo Nordisk and Eli Lilly in obesity drugs.
Via
Investor's Business Daily
Earnings Scheduled For August 2, 2022
August 02, 2022
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
Via
Benzinga
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
July 21, 2022
Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Via
Benzinga
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
July 20, 2022
Via
Benzinga
Stocks Shift Higher as Strong Earnings Continue
July 20, 2022
The broader market has rebounded from this morning's losses midday.
Via
Talk Markets
This Communication Services Stock Is Trading Higher By Over 82%, Here Are 45 Stocks Moving In Wednesday's Mid-Day Session
July 20, 2022
Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 82.2% to $2.6787. Direct Digital Holdings said its supply-side advertising platform, Colossus SSP, reported a 540% year-over-year...
Via
Benzinga
Tech Shares Move Higher, Nasdaq Jumps 200 Points
July 20, 2022
U.S. stocks traded higher midway through trading, with the NASDAQ Composite gaining more than 200 points on Wednesday.
Via
Benzinga
Rhythm Shares Shoot Higher Following Pre-marketing Authorization From French Regulatory For Multisystem Disorder Candidate
July 20, 2022
The French National Agency for Medicines and Health Products Safety (ANSM) and Haute Autorité de santé (HAS) have granted pre-marketing authorization AP1 (early access authorization), for Rhythm...
Via
Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
July 18, 2022
Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
July 15, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 13, 2022
Via
Benzinga
Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday
July 18, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering...
Via
Benzinga
This Healthcare Stock is Down By More Than 50%: Here's 25 Stocks Moving Premarket
July 13, 2022
Gainers
Via
Benzinga
Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday
July 14, 2022
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.
Via
Benzinga
Crude Oil Prices Fall Sharply; Greenwich LifeSciences Shares Spike Higher
July 12, 2022
U.S. stocks traded mixed toward the end of trading after recording losses in the previous session.
Via
Benzinga
Boeing, PriceSmart And 80 Biggest Movers From Yesterday
July 13, 2022
Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 12, 2022
Via
Benzinga
Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session
July 12, 2022
Gainers
Via
Benzinga
Rhythm Shares Climb Following Positive Interim Results From Mid-Stage Obesity Study
July 12, 2022
Rhythm Pharmaceuticals (NASDAQ: RYTM) announced positive interim results from a Phase 2 clinical trial evaluating setmelanotide for the treatment of severe obesity and hyperphagia in people living with...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
July 07, 2022
Gainers
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
July 01, 2022
The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment.
Via
Benzinga
33 Stocks Moving In Friday's Mid-Day Session
June 17, 2022
Gainers Revlon, Inc. (NYSE: REV) gained 81.5% to $3.54 following a report suggesting Reliance Industries is considering buying out the company, which recently filed for bankruptcy.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.